Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants

Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (< 30 weeks), birth weights (< 1250 g), or more complicated clinical courses. To determine if such strategies reduce detection of cystic peri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric radiology 1999-05, Vol.29 (5), p.347-352
Hauptverfasser: TOWNSEND, S. F, RUMACK, C. M, THILO, E. H, MERENSTEIN, G. B, ROSENBERG, A. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 352
container_issue 5
container_start_page 347
container_title Pediatric radiology
container_volume 29
creator TOWNSEND, S. F
RUMACK, C. M
THILO, E. H
MERENSTEIN, G. B
ROSENBERG, A. A
description Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (< 30 weeks), birth weights (< 1250 g), or more complicated clinical courses. To determine if such strategies reduce detection of cystic periventricular leukomalacia (cPVL) and persistent ventricular enlargement (pVE)--late sonographic abnormalities highly predictive of adverse neurodevelopment in preterm infants. Timing, findings, and number of neurosonograms were reviewed for all survivors born at < or = 32 weeks' gestation at University Hospital, Denver, Colo., between January 1992 and June 1995. Of 236 surviving infants, 61 (26%) were never scanned, and 175 (74%) had a total of 432 scans. Only 106 infants (45%) had a neurosonogram on or after 28 days (timed to detect all cPVL/pVE). Eleven infants (4.7%) had cPVL, and 19 (8%) had pVE. Severity of clinical course did not predict development of cPVL, but was a better predictor of pVE. Initial neurosonograms were normal in 6/11 (55%) with cPVL and 5/19 (26%) with pVE. Screening declined from 86% of infants in 1992 (average 2.54 neurosonograms each), to 64% by 1994-1995 (average of 2.22 neurosonograms each). Infants > 30 weeks' gestation comprised 55 of 61 patients without any neurosonograms (90%), 4 of 11 patients with cPVL (36%), and 4 of 19 patients with pVE (21%). Screening neurosonography has declined from 1992 to 1995, particularly in larger premature infants (30-32 weeks' gestation) who remain at risk for cPVL and pVE. Clinical course or results of initial studies do not always predict the development of these late abnormalities. We recommend that one neurosonogram be done at > or = 4 weeks of age in all premature infants < or = 32 weeks' gestation, regardless of birth weight, clinical course, or results of prior studies. An earlier neurosonogram should be obtained for infants < 30 weeks' gestation in the second week of life to detect complications of intracranial hemorrhage.
doi_str_mv 10.1007/s002470050604
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69846533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1316087391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-886c66a2cfc2d03a2ab37b2ec02df8755b0dc15c88fdfe899f77bbbfd65c10083</originalsourceid><addsrcrecordid>eNp90c9rFTEQB_AgFvusHr1KEBEvq5Nkk80eS_FH4YEXPS_Z7OQ1dTdZk6zg_-Af3ch7YPXQSxIyHwbmO4S8YPCOAXTvMwBvOwAJCtpHZMdawRvW9_ox2YEA1kDb9ufkac63ACAkE0_IOQOhOWd8R37vTUEacEsxxxAPyaw33tJsE2Lw4UB9pn5ZYyomFFoiLTdIJ28OIeZaio6umPxPDCV5u80m0Rm373Exs7HeUBMmer-IoZ4HXOoX9YGuCQumpT5dbZ-fkTNn5ozPT_cF-fbxw9erz83-y6frq8t9Y0WnS6O1skoZbp3lEwjDzSi6kaMFPjndSTnCZJm0WrvJoe5713XjOLpJSVsz0-KCvDn2XVP8sWEuw-KzxXk2AeOWB9XrVkkhKnz7IKxh91xIzWSlr_6jt3FLoY4xcM6V1DX5ipojsjXunNANa_KLSb8GBsOfdQ7_rLP6l6em27jgdE8f91fB6xMw2ZrZJROsz39dpxQXIO4AvlSqbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222658513</pqid></control><display><type>article</type><title>Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>TOWNSEND, S. F ; RUMACK, C. M ; THILO, E. H ; MERENSTEIN, G. B ; ROSENBERG, A. A</creator><creatorcontrib>TOWNSEND, S. F ; RUMACK, C. M ; THILO, E. H ; MERENSTEIN, G. B ; ROSENBERG, A. A</creatorcontrib><description>Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (&lt; 30 weeks), birth weights (&lt; 1250 g), or more complicated clinical courses. To determine if such strategies reduce detection of cystic periventricular leukomalacia (cPVL) and persistent ventricular enlargement (pVE)--late sonographic abnormalities highly predictive of adverse neurodevelopment in preterm infants. Timing, findings, and number of neurosonograms were reviewed for all survivors born at &lt; or = 32 weeks' gestation at University Hospital, Denver, Colo., between January 1992 and June 1995. Of 236 surviving infants, 61 (26%) were never scanned, and 175 (74%) had a total of 432 scans. Only 106 infants (45%) had a neurosonogram on or after 28 days (timed to detect all cPVL/pVE). Eleven infants (4.7%) had cPVL, and 19 (8%) had pVE. Severity of clinical course did not predict development of cPVL, but was a better predictor of pVE. Initial neurosonograms were normal in 6/11 (55%) with cPVL and 5/19 (26%) with pVE. Screening declined from 86% of infants in 1992 (average 2.54 neurosonograms each), to 64% by 1994-1995 (average of 2.22 neurosonograms each). Infants &gt; 30 weeks' gestation comprised 55 of 61 patients without any neurosonograms (90%), 4 of 11 patients with cPVL (36%), and 4 of 19 patients with pVE (21%). Screening neurosonography has declined from 1992 to 1995, particularly in larger premature infants (30-32 weeks' gestation) who remain at risk for cPVL and pVE. Clinical course or results of initial studies do not always predict the development of these late abnormalities. We recommend that one neurosonogram be done at &gt; or = 4 weeks of age in all premature infants &lt; or = 32 weeks' gestation, regardless of birth weight, clinical course, or results of prior studies. An earlier neurosonogram should be obtained for infants &lt; 30 weeks' gestation in the second week of life to detect complications of intracranial hemorrhage.</description><identifier>ISSN: 0301-0449</identifier><identifier>EISSN: 1432-1998</identifier><identifier>DOI: 10.1007/s002470050604</identifier><identifier>PMID: 10382212</identifier><identifier>CODEN: PDRYA5</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Biological and medical sciences ; Birth Weight ; Cerebral Ventricles - abnormalities ; Cerebral Ventricles - diagnostic imaging ; Gestational Age ; Humans ; Infant ; Infant, Newborn ; Infant, Premature ; Leukomalacia, Periventricular - diagnostic imaging ; Medical sciences ; Neurology ; Predictive Value of Tests ; Retrospective Studies ; Ultrasonography ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Pediatric radiology, 1999-05, Vol.29 (5), p.347-352</ispartof><rights>1999 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-886c66a2cfc2d03a2ab37b2ec02df8755b0dc15c88fdfe899f77bbbfd65c10083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1766230$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10382212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TOWNSEND, S. F</creatorcontrib><creatorcontrib>RUMACK, C. M</creatorcontrib><creatorcontrib>THILO, E. H</creatorcontrib><creatorcontrib>MERENSTEIN, G. B</creatorcontrib><creatorcontrib>ROSENBERG, A. A</creatorcontrib><title>Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants</title><title>Pediatric radiology</title><addtitle>Pediatr Radiol</addtitle><description>Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (&lt; 30 weeks), birth weights (&lt; 1250 g), or more complicated clinical courses. To determine if such strategies reduce detection of cystic periventricular leukomalacia (cPVL) and persistent ventricular enlargement (pVE)--late sonographic abnormalities highly predictive of adverse neurodevelopment in preterm infants. Timing, findings, and number of neurosonograms were reviewed for all survivors born at &lt; or = 32 weeks' gestation at University Hospital, Denver, Colo., between January 1992 and June 1995. Of 236 surviving infants, 61 (26%) were never scanned, and 175 (74%) had a total of 432 scans. Only 106 infants (45%) had a neurosonogram on or after 28 days (timed to detect all cPVL/pVE). Eleven infants (4.7%) had cPVL, and 19 (8%) had pVE. Severity of clinical course did not predict development of cPVL, but was a better predictor of pVE. Initial neurosonograms were normal in 6/11 (55%) with cPVL and 5/19 (26%) with pVE. Screening declined from 86% of infants in 1992 (average 2.54 neurosonograms each), to 64% by 1994-1995 (average of 2.22 neurosonograms each). Infants &gt; 30 weeks' gestation comprised 55 of 61 patients without any neurosonograms (90%), 4 of 11 patients with cPVL (36%), and 4 of 19 patients with pVE (21%). Screening neurosonography has declined from 1992 to 1995, particularly in larger premature infants (30-32 weeks' gestation) who remain at risk for cPVL and pVE. Clinical course or results of initial studies do not always predict the development of these late abnormalities. We recommend that one neurosonogram be done at &gt; or = 4 weeks of age in all premature infants &lt; or = 32 weeks' gestation, regardless of birth weight, clinical course, or results of prior studies. An earlier neurosonogram should be obtained for infants &lt; 30 weeks' gestation in the second week of life to detect complications of intracranial hemorrhage.</description><subject>Biological and medical sciences</subject><subject>Birth Weight</subject><subject>Cerebral Ventricles - abnormalities</subject><subject>Cerebral Ventricles - diagnostic imaging</subject><subject>Gestational Age</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Leukomalacia, Periventricular - diagnostic imaging</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Ultrasonography</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0301-0449</issn><issn>1432-1998</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp90c9rFTEQB_AgFvusHr1KEBEvq5Nkk80eS_FH4YEXPS_Z7OQ1dTdZk6zg_-Af3ch7YPXQSxIyHwbmO4S8YPCOAXTvMwBvOwAJCtpHZMdawRvW9_ox2YEA1kDb9ufkac63ACAkE0_IOQOhOWd8R37vTUEacEsxxxAPyaw33tJsE2Lw4UB9pn5ZYyomFFoiLTdIJ28OIeZaio6umPxPDCV5u80m0Rm373Exs7HeUBMmer-IoZ4HXOoX9YGuCQumpT5dbZ-fkTNn5ozPT_cF-fbxw9erz83-y6frq8t9Y0WnS6O1skoZbp3lEwjDzSi6kaMFPjndSTnCZJm0WrvJoe5713XjOLpJSVsz0-KCvDn2XVP8sWEuw-KzxXk2AeOWB9XrVkkhKnz7IKxh91xIzWSlr_6jt3FLoY4xcM6V1DX5ipojsjXunNANa_KLSb8GBsOfdQ7_rLP6l6em27jgdE8f91fB6xMw2ZrZJROsz39dpxQXIO4AvlSqbA</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>TOWNSEND, S. F</creator><creator>RUMACK, C. M</creator><creator>THILO, E. H</creator><creator>MERENSTEIN, G. B</creator><creator>ROSENBERG, A. A</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants</title><author>TOWNSEND, S. F ; RUMACK, C. M ; THILO, E. H ; MERENSTEIN, G. B ; ROSENBERG, A. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-886c66a2cfc2d03a2ab37b2ec02df8755b0dc15c88fdfe899f77bbbfd65c10083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Birth Weight</topic><topic>Cerebral Ventricles - abnormalities</topic><topic>Cerebral Ventricles - diagnostic imaging</topic><topic>Gestational Age</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Leukomalacia, Periventricular - diagnostic imaging</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Ultrasonography</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TOWNSEND, S. F</creatorcontrib><creatorcontrib>RUMACK, C. M</creatorcontrib><creatorcontrib>THILO, E. H</creatorcontrib><creatorcontrib>MERENSTEIN, G. B</creatorcontrib><creatorcontrib>ROSENBERG, A. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TOWNSEND, S. F</au><au>RUMACK, C. M</au><au>THILO, E. H</au><au>MERENSTEIN, G. B</au><au>ROSENBERG, A. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants</atitle><jtitle>Pediatric radiology</jtitle><addtitle>Pediatr Radiol</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>29</volume><issue>5</issue><spage>347</spage><epage>352</epage><pages>347-352</pages><issn>0301-0449</issn><eissn>1432-1998</eissn><coden>PDRYA5</coden><abstract>Recent cost-containment strategies suggest limiting screening neurosonograms to the second week of life in premature infants with lower gestational ages (&lt; 30 weeks), birth weights (&lt; 1250 g), or more complicated clinical courses. To determine if such strategies reduce detection of cystic periventricular leukomalacia (cPVL) and persistent ventricular enlargement (pVE)--late sonographic abnormalities highly predictive of adverse neurodevelopment in preterm infants. Timing, findings, and number of neurosonograms were reviewed for all survivors born at &lt; or = 32 weeks' gestation at University Hospital, Denver, Colo., between January 1992 and June 1995. Of 236 surviving infants, 61 (26%) were never scanned, and 175 (74%) had a total of 432 scans. Only 106 infants (45%) had a neurosonogram on or after 28 days (timed to detect all cPVL/pVE). Eleven infants (4.7%) had cPVL, and 19 (8%) had pVE. Severity of clinical course did not predict development of cPVL, but was a better predictor of pVE. Initial neurosonograms were normal in 6/11 (55%) with cPVL and 5/19 (26%) with pVE. Screening declined from 86% of infants in 1992 (average 2.54 neurosonograms each), to 64% by 1994-1995 (average of 2.22 neurosonograms each). Infants &gt; 30 weeks' gestation comprised 55 of 61 patients without any neurosonograms (90%), 4 of 11 patients with cPVL (36%), and 4 of 19 patients with pVE (21%). Screening neurosonography has declined from 1992 to 1995, particularly in larger premature infants (30-32 weeks' gestation) who remain at risk for cPVL and pVE. Clinical course or results of initial studies do not always predict the development of these late abnormalities. We recommend that one neurosonogram be done at &gt; or = 4 weeks of age in all premature infants &lt; or = 32 weeks' gestation, regardless of birth weight, clinical course, or results of prior studies. An earlier neurosonogram should be obtained for infants &lt; 30 weeks' gestation in the second week of life to detect complications of intracranial hemorrhage.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>10382212</pmid><doi>10.1007/s002470050604</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-0449
ispartof Pediatric radiology, 1999-05, Vol.29 (5), p.347-352
issn 0301-0449
1432-1998
language eng
recordid cdi_proquest_miscellaneous_69846533
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Biological and medical sciences
Birth Weight
Cerebral Ventricles - abnormalities
Cerebral Ventricles - diagnostic imaging
Gestational Age
Humans
Infant
Infant, Newborn
Infant, Premature
Leukomalacia, Periventricular - diagnostic imaging
Medical sciences
Neurology
Predictive Value of Tests
Retrospective Studies
Ultrasonography
Vascular diseases and vascular malformations of the nervous system
title Late neurosonographic screening is important to the diagnosis of periventricular leukomalacia and ventricular enlargement in preterm infants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A30%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20neurosonographic%20screening%20is%20important%20to%20the%20diagnosis%20of%20periventricular%20leukomalacia%20and%20ventricular%20enlargement%20in%20preterm%20infants&rft.jtitle=Pediatric%20radiology&rft.au=TOWNSEND,%20S.%20F&rft.date=1999-05-01&rft.volume=29&rft.issue=5&rft.spage=347&rft.epage=352&rft.pages=347-352&rft.issn=0301-0449&rft.eissn=1432-1998&rft.coden=PDRYA5&rft_id=info:doi/10.1007/s002470050604&rft_dat=%3Cproquest_cross%3E1316087391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222658513&rft_id=info:pmid/10382212&rfr_iscdi=true